Nabriva Therapeutics plc Uncategorized Contracts & Agreements
7 Contracts & Agreements
- Letter Agreement, dated January 31, 2023, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD International Business GmbH and Merck Sharp & Dohme LLC (Filed With SEC on February 6, 2023)
- Open Market Sale AgreementSM, dated May 6, 2021, by and between Nabriva Therapeutics plc and Jefferies LLC (Filed With SEC on May 6, 2021)
- Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 11, 2021)
- Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 12, 2020)
- Open Market Sale AgreementSM, dated June 25, 2019, by and between Nabriva Therapeutics plc and Jefferies LLC (Filed With SEC on June 25, 2019)
- Commercial Packaging Agreement by and between Zavante Therapeutics, Inc. and AndersonBrecon Inc., d/b/a PCI of Illinois, dated as of December 26, 2017 (Filed With SEC on November 6, 2018)
- Amended and Restated Three-Way Agreement by and between Laboratorios ERN, S.A, Ercros, S.A., and Zavante Therapeutics, Inc., dated as of July 28, 2016 (Filed With SEC on November 6, 2018)
